breast cancer

Change in HER2 status after treatment with Herceptin

harminka — Thu, 04 Sep 2008 00:18:33 -0500

Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery.

Growth factor predicts poor outcome in breast cancer

harminka — Sat, 30 Aug 2008 04:32:09 -0500

The response to insulin-like growth factor 1 (IGF-I) in breast cancer cells predicts an aggressive tumor that is less likely to respond to treatment, said researchers at Baylor College of Medicine in a report that appears in the current issue of the Journal of Clinical Oncology.

Breastfeeding, other factors may affect risk of breast cancer type

harminka — Mon, 25 Aug 2008 14:02:04 -0500

Factors such as age at menopause as well as a woman's breastfeeding practices can influence her risk of developing certain types of breast cancer.

New drug target against virulent type of breast cancer

harminka — Mon, 25 Aug 2008 13:16:32 -0500

Tumor cells in a particular subset of breast cancer patients churn out too much of a protein called ErbB2 -- also often called HER2 -- which drives the cells to proliferate unchecked. Patients unlucky enough to be in this group -- about one in four -- have poorer prognoses and clinical outcomes than those who don't.

Women exposed to negative life events at greater risk of breast cancer

harminka — Mon, 25 Aug 2008 07:40:21 -0500

Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel.

Dense tissue promotes aggressive cancers

harminka — Sun, 24 Aug 2008 07:01:06 -0500

New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue.

First step towards switching off breast cancer and leukaemia

harminka — Fri, 08 Aug 2008 12:53:53 -0500

Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia.

How chemo kills tumors

harminka — Thu, 07 Aug 2008 11:16:34 -0500

Dr Stephen Taylor and Karen Gascoigne at the University’s Faculty of Life Sciences have taken a new systematic approach to studying anti-mitotic drugs, which are used extensively for breast or ovarian cancer in the UK.

Emotional work of disclosing cancer diagnosis

harminka — Mon, 04 Aug 2008 09:17:05 -0500

Women diagnosed with breast cancer shoulder the emotional burden of disclosing their diagnosis to loved ones, managing the feelings of others at precisely the time when they need support themselves, according to research to be presented at the annual meeting of the American Sociological Association (ASA).

Convenience of screening mammography facilities is important in patient retention

harminka — Sun, 03 Aug 2008 13:00:18 -0500

Patients cite "convenience to home or work" as the main reason they changed mammography facilities, according to a recent study conducted by researchers at the University of Cincinnati Medical Center and The Barrett Center in Cincinnati, OH.

Minorities less likely to know about breast cancer treatment options

harminka — Thu, 31 Jul 2008 10:50:11 -0500

Nearly half of women treated for breast cancer did not know that their odds of being alive after five years are roughly the same whether they undergo mastectomy or breast conserving surgery.

2 different breast cancer screening strategies are equally effective

harminka — Wed, 30 Jul 2008 01:11:31 -0500

An organized population-based breast cancer screening program in Norway and an approach to screening that relies on physician- and self-referrals in Vermont are equally sensitive for detecting cancer, researchers report in the July 29 online issue of the Journal of the National Cancer Institute. But the recall rate for abnormal mammograms was lower in Norway.